Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 02, 2025 06:41 ET | Source: Research and Markets

Human Leukocyte Antigen (HLA) Targeted Therapy Market Research 2026: Advances Driven by Novel CAR-Treg and Bispecific T-Cell Engager Programs from Quell Therapeutics and Daiichi Sankyo

Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Human Leukocyte Antigen (HLA) Targeted Therapy, Clinical Trials, Therapeutic Approaches & Market Opportunity Insight 2026" report has been added to...